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infective endocarditis patients: an
observational study experience from
tertiary care center Karachi Pakistan
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Abstract
Background: The study analyzed microbiological and antimicrobial susceptibility profile of organisms isolated from
patients with infective endocarditis (2015–17) and compared disease outcomes in cohorts of endocarditis patient
with history of prior invasive vascular intervention (high risk group) vs those without (native valve group). We
hypothesized that high risk group would be more likely to have severe disease outcomes.
Methods: This was a prospective cohort study (2015–17). All blood and cardiac tissue samples of enrolled
patients suspected of endocarditis according to modified Duke’s criteria were followed for microbiological and
antimicrobial susceptibility profile. The high risk group was compared with the native valve group with 90 day follow
up to determine difference in clinical course and outcome in terms of disease severity (defined as any patient with
endocarditis undergoing surgical management, readmission or dying). The data was analyzed using SPSS 21.0 software
and chi-square test. 90 day mortality was calculated using Kaplan Meier survival curves.
Results: Total 104 patients with endocarditis were enrolled. Overall culture positivity rate was 71.2%. Streptococcus
species were the most common isolate (36.7%), followed by S. aureus (17.3%) cases. In Streptococcus species,
14.2% showed intermediate susceptibility to penicillin. Thirty six patients were included in the cohort analysis.
A poor outcome was seen in 85.7% high risk group as compared to 50% of native valve group. The overall mortality
rate was 19.4%.
Conclusions: We found Streptococcus species to be the predominant pathogen for endocarditis overall. However
Staphylococcus aureus predominated native valve group. High risk group showed more complicated clinical course.
Keywords: Infective endocarditis, Surgical intervention, Microbiological profile, Clinical features, Pakistan
Background
Infective Endocarditis (IE) is associated with significant
disease burden, globally. In 2010, IE was associated with
1.58 million disability-adjusted life-years or years of
healthy life lost as a result of death and nonfatal illness
or impairment [1]. In past few decades the epidemiology,
microbiologic profile and treatment outcomes of pa-
tients with IE in developed countries have changed sig-
nificantly. Rheumatic heart disease (RHD) which was
once considered the main risk factor for IE is now being
superseded by other factors such as invasive vascular in-
terventions (IVI), prosthetic cardiac devices, implants
and correction procedures for congenital cardiac defects
[1]. Up to 30% of all IE cases have been associated with
such factors in developed countries [2]. In Pakistan,
there is a mix of population of various socioeconomic
strata. While high infant mortality and burden of com-
mon infectious diseases including RHD is common in
lower strata, there is an expanding population on the
other end of the spectrum that is able to afford recent
advances in medical care. They have risk factors of IE
similar to modern world, such as cardiac implants,
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invasive vascular interventions and correction of con-
genital defects. Thus, it is important to study the chan-
ging epidemiology and microbiologic profile of patients
with endocarditis that may provide better treatment /
management strategies in local scenario.
IE studies conducted in Pakistan mainly retrospect-
ively designed; have highlighted younger population be-
ing affected more frequently than those reported in the
western world [3–6]. As regards etiologic agents, most
published studies have limitations in terms of poor sen-
sitivity of bacterial culture methods utilized, such as
conventional in-house blood culture methods.; as a re-
sult up to 50% of IE cases are reported as culture nega-
tive [7, 8]. Lack of authentic data of the common
etiologic agents and their susceptibility pattern seriously
hampers the choice of empirical antibiotic treatment.
Moreover, there is a complete dearth of information that
correlates use of vascular / cardiac procedure and im-
plants with IE, disease severity and treatment outcomes
in Pakistan.
IE patients with cardiac interventions / prosthetic valves
have worse outcomes or complicated disease course com-
pared to patients with native valves. A study in Cleveland
compared long term post-surgery survival amongst pa-
tient with endocarditis having native valve endocarditis
(NVE) and prosthetic valve disease (PVE) and reported
improved survival in patients with NVE [9]. This may pos-
sibly be due to increased disease severity in patients with
PVE. Brenan et al. in their study at 605 centers within the
Society of Thoracic Surgeons Adult Cardiac Surgery Data-
base showed an elevated 12-year risk of reoperation and
endocarditis amongst bio prosthesis patients [10]. In this
study we analyzed the frequency of common etiological
agents of IE using the highly sensitive standard automated
system of blood culture methods (Bactec 9240). In
addition, we assessed patient characteristics along with
management outcomes amongst those with history of
prior IVI labeled as high risk group (HRG) vs those with-
out such risk factors termed as native valve group (NVG)
and performed survival analysis for 90-day mortality. We
hypothesized that HRG would be more likely to have se-
vere disease outcomes, require further surgical interven-
tions or readmissions, or die as opposed to conservative
medical treatment.
Methods
This was a prospective cohort study performed at the
Clinical Laboratory (microbiology section) and cardio-
thoracic surgery of the Aga Khan University Hospital
(AKUH), Karachi, Pakistan 2015–17. This is the biggest
diagnostic laboratory set-up in Pakistan. We receive
average of 1200–1500 blood culture samples per week
from more than 200 outreach blood sample collection
units in all major cities of Pakistan: hence the data rep-
resents country wide distribution.
We identified suspected IE patients from samples sub-
mitted at the clinical lab: all blood and relevant tissue
samples (cardiac vegetation, cardiac valves, valvular ab-
scess etc.) that were received with history suggestive of
endocarditis were enrolled and verbal consent obtained
for it. We followed blood / tissue culture to determine
the microbiological and antimicrobial susceptibility pro-
file of all recruited patients. The study was exempted
from ethical approval by the research ethics committee
under study number 3721-Pat-ERC-15 of the Aga Khan
University hospital.
In addition, we closely followed patients treated at
AKUH; these patients were divided into two groups. A
cohort of IE patients with prior history of prosthetic
heart implants /prior cardiac intervention, valve repair/
replacements, Coronary artery bypass (CABG), angiog-
raphy or angioplasty, correction of congenital cardiac
vascular and valvular defects, pacemaker insertions
within the last 12 years from time of enrollment in this
study were classified as HRG and those without were la-
beled as NVG (see Fig. 1). To illustrate clinical charac-
teristics and outcomes with respect to medical and
surgical management, these two cohorts of patients were
followed up till 90 days.
All suspected patients admitted under the service of
internal medicine and cardio thoracic surgery fulfilling
the modified Duke’s criteria (MoDC) for IE [2] were
considered eligible and were enrolled. Eligible patients
who could not be contacted for history were excluded.
Any samples with damaged blood culture bottles or tis-
sue in unsterile container were rejected and not included
in the study. Details of patient’s clinical and microbio-
logical profile were collected prospectively and entered
in the predefined data collection form. Confidentiality
was maintained by giving unique research identification
number, and forms were kept under lock and key. De-
tails included patient demographics, clinical presenta-
tion, duration of illness, use of prior antibiotics for the
illness, predisposing cardiac condition, history of inva-
sive cardiac procedures, microbiological and radiological
findings along with echocardiography results; medical
and surgical management details were recorded along
with treatment outcome. Outcome in terms of disease
severity was defined as any patient with IE undergoing
surgical management, readmission or dying.
For microbiological profile, specimens were processed
according to the standard techniques. Bactec 9240
automated system was used for blood culture as per
Clinical & Laboratory Standards Institute (CLSI) proto-
col [11]. Tissue cultures were incubated for 21 days,
antibiotic susceptibility testing was performed by disc
diffusion method or Minimal inhibitory concentration
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(MIC) methods as recommended by CLSI and British
Society for Antimicrobial Chemotherapy (BSAC) pro-
tocols, whichever was applicable. MIC was performed
using Vitek2 system or E-strips as recommended.
Microbiological outcome was determined as type /
frequency of microorganisms isolated, antimicrobial
susceptibility pattern of those isolates. All negative
cases were reported “no growth” after incubation of
21 days.
Statistical analysis
The data was analyzed using SPSS 21.0 software. In de-
scriptive analysis mean and standard deviation of the
continuous variables i.e. age, antibiotic MICs, duration
of hospital stay etc. were calculated. Frequency and per-
centage of the categorical variables i.e. gender, etiological
agent, antibiotic susceptibility pattern, clinical character-
istics and surgical outcome were calculated. Risk of poor
outcome was compared between HRG and NVG using
chi-square test and difference was significant if p-value
was ≤0.05. Kaplan Meier curves were generated to com-
pare survival of HRG and NVG patients.
Results
During the study period, 104 patients with clinical diag-
nosis of IE were prospectively enrolled (Fig. 1). Mean
age of patients was 34.84 years with 72.1% being males.
Adult representation was 84.6% and 15.4% were below
16 years. Using the MoDC 65.4% (n = 68) were identified
as “definite cases of infective endocarditis” rest fell in
the “possible case”. Cultures were sent on all 104 en-
rolled patients. Approximately 35% (n = 36) of patients
were admitted at AKUH and were followed up for clin-
ical outcomes.
Microbiological profile: Blood culture samples for la-
boratory diagnosis only, were received for 82.7% of the
enrolled cases. Of these, 47.6% cases had 3 sets, while
14.6% had 2 sets of blood culture samples. For 10.6%
cases both blood culture and cardiac tissues were re-
ceived, while cardiac tissue or abscess pus aspirate sam-
ples without concomitant blood cultures were received
in 6.7% of cases. Overall culture positivity rate was
71.2% (n = 74).
Among Gram positive organisms, Streptococcus spe-
cies were the most common isolate (36.7%), predomin-
antly S. mitis, followed by Staphylococcus species
(23.1%). In Streptococcus species, 14.2% showed inter-
mediate susceptibility to penicillin, (MIC50 = 0.12 μg/
ml, MIC90 = 0.25 μg/ml); S. oralis being the species
with the highest MIC range (0.06 μg/ml – 0.5 μg/ml).
Half of the enterococcus isolates in the study were
resistant to ampicillin, while all were sensitive to
Vancomycin. S. aureus was isolated in 17.3% cases.
Vancomycin MICs were performed only on Methicillin
resistant strains of S. aureus (MIC range 0.5–1 μg/ml)
and coagulase negative staphylococci (MIC 1 μg/ml).
All MRSA strains were sensitive to Vancomycin. Hae-
mophilus actinomycetemcomitans, Klebsiella pneumo-
niae, Acinetobacter species were isolated in 2.9%
samples as primary pathogen and were found sensitive
to third generation cephalosporin and carbapenem
groups of antibiotics. Three patients had fungal endo-
carditis with Candida albicans, Aspergillus niger, Fusar-
ium species, each. Table 1 shows details of frequency,
type and antibiotic susceptibility of etiologic agents de-
tected from blood and tissue cultures.
Fig. 1 Study workflow for patient enrollment and group assignment.
Description of study workflow for patient enrollment and assignment
of groups for sub analysis (2015–2017). AKUH = Aga Khan University
Hospital, HRG = High risk group, NVG = Native valve group, M Rx
= Medical management, S Rx = Surgical management
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AKUH patient cohort analysis
Table 2 shows the frequency and association of patient
demographics and clinical characteristics with HRG at
the time of presentation. Table 3 presents the frequen-
cies and risk of clinical outcomes with the HRG. Thirty
six patients were included in the cohort analysis. The
HRG included 14 patients whereas 22 were included in
the NVG. Mean age of patients in HRG was 45 years
and 38 years in NVG. Male predominance was seen in
both groups. Eighty five percent cases in HRG were di-
agnosed as definite IE, 41.6% presenting with acute
symptoms. In the NVG, 72.2% were diagnosed as defin-
ite IE with acute symptoms in 54.4% patients. Culture
positivity rate was 71.4% in HRG and 90.9% in NVG.
RHD was seen in 18.1% cases of NVG only. In the HRG,
prosthetic cardiac valve and implants (stents, pace-
makers) were seen in 78.5% cases. A high proportion of
HRG patients had congenital heart disease (42.8%), who
underwent invasive intervention in the past. Most patients
presented with fever. Breathlessness was seen in 35.7%
HRG and 54.5% NVG. Edema was present in 18% NVG
patients. Signs of sepsis were more frequent in NVG
(27.2% vs. 7.1% in HRG). Multi organ dysfunction includ-
ing acute renal injury (AKI), splenomegaly, hepatomegaly,
lymphadenopathy, pulmonary symptoms were seen in
31.81% of NVG vs 28.58% in HRG. Murmur was present
in 36.6% NVG patients. Presence of vegetation was seen
in almost all patients in HRG (92.8%) as shown in Table 2.
Although too small a number to be significant, mitral
valve prolapse was seen only in the NVG (13.6%) and pul-
monary regurgitation only in HRG (14.2%).
Regarding clinical outcomes, the risk of disease severity
was higher amongst the HRG than NVG (Table 3), with
85.7% HRG patients having poorer outcome compared to
Table 1 Microbiological profile and antibiotic resistance pattern of isolates from patient with infective endocarditis received at the
AKUH clinical laboratory (n = 104)
Microorganism Total number cases
n = 104(%)
Percent resistance of antibiotic for the species
CN CI ER PE VA CH OX CP AM CR
Gram positive organism 68 (65.4)
Staphylococcus species 24 (23.1)
•S. aureus 18 (17.3) 27.0 22.2 50.0 100 00 00 77. 44.4 – –
MSSA 4 (3.8)
MRSA 14 (13.5)
•CONS 6 (5.8) 16.6 16.6 33.3 100 00 00 83.3 60.0 – –
Streptococcus species 36 (34.7) NP 20.0 40.0 14.2 00 – – – – 02.8
•S. pneumoniae 2 (1.9)
•S. mitis 8 (7.7)
•S. oralis 5 (4.8)
•S. sanguis 3 (2.9)
•S. viridans 3 (2.9)
•S. milleri 1 (1.0)
•S. bovis 3 (2.9)
•Streptococcus species 5 (4.8)
•Granulicatella adiacens 1 (1.0)
•Aerococcus viridans 2 (1.9)
•Gemella haemolysan 1 (1.0)
Enterococcus species 4 (3.8) 25.0 – 50.0 50.0 00 25.0 – – 50.0 –
Corynebaterium species 4 (3.8) 25 00 00 – 00 25.0 – 00 –
Gram negative organism 3 (2.9) 00 – – – – – – 33.3 – 00
Haemophilus actinomycetemcomitans, Klebsiella pneumoniae,
Acinetobacter species.
Fungus 3 (2.9) No resistance to azoles and Amphotericin
Candida albicans, Aspergillus niger, Fusarium species
Culture negative cases 30 (28.8) –
CN Gentamicin, CI Clindamycin, ER Erythromycin, PE Penicillin, VA Vancomycin, CH Chloramphenicol, OX Oxacillin, CP Ciprofloxacin CR Ceftriaxone, MRSA Methicillin
resistant Staphylococcus aureus, MSSA Methicillin-Sensitive Staphylococcus aureus
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50% of NVG. However, more deaths were seen in the na-
tive valve group (22.72%), despite not achieving statistical
significance probably due to small number of events. The
Kaplan Meier curve is shown in Fig. 2. The risk of embol-
ism or infarct was higher with NVG (45.5%); the involve-
ment of central nervous system seen exclusively in this
group (27.7%). Thirty six percent cases of the HRG had
complications during hospital stay (NVG = 27.2%). Large
vegetation was the most common indication for surgery in
both groups (HRG= 64.2%, NVG= 22.7%), but signifi-
cantly associated with HRG.
Additional file 1: Table S4 shows clinical presentations
and outcomes specific to the organisms isolated amongst
Infective Endocarditis patients admitted at AKUH 2015–
2017. Streptococcus spp. was equally prevalent in both
groups (22.7% in NVG vs 21.4% in HRG). In the NVG,
cases presented with murmur, thromboembolic (TE)
event, rash, cardiac tamponade and abscess (S. oralis) on
echocardiograph at presentation. All these cases were
treated medically and had Penicillin MIC range of 0.03–
0.5 μg/ml. There was one death; the patient’s isolate had
intermediate susceptibility to Penicillin with MIC of
0.12 μg/ml. In the HRG, 3 cases of Streptococcus species
were seen; Penicillin MIC range was 0.015–0.012 μg/ml.
Only one presented with an abscess and the infecting
organism in this case was S. sanguis. S.aureus was seen
more in the NVG compared to HRG. MRSA endocarditis
cases presented with TE event, AKI, raised infectious
Table 2 Frequency and association of patient demographics, clinical characteristics and underlying disease severity with HRG at the
time of presentation of IE patients admitted at AKUH 2015–2017 (n = 36)
PATIENT CHARACTERISTICS HRG N = 14 NVG N = 22 p-value Odds Ratio (Confidence interval)
Mean Age 45 38 – –
Gender: Male 8 15 0.501 0.838 (0.490–1.432)
MoDC
•Definite 12 16 0.361 1.179 (0.844–1.645)
•Probable 2 6 0.361 0.524 (0.122–2.240)
Acute clinical presentation 5 12 0.270 0.655 (0.294–1.457)
Sub-acute presentation 9 10 0.270 1.414 (0.775–2.581)
Positive culture 10 20 0.126 0.786 (0.550–1.122)
Pure culture growth 14 18 0.091 1.222 (1.004–1.488)
Rheumatic heart disease 0 4 0.090
Prosthetic heart valve / cardiac implants 11 0 – –
Congenital heart disease 6 5 0.201 1.886 (0.708–5.022)
Severity at presentation
Signs of thromboembolisma 2 7 0.236 0.449(0.108–1.860)
Sepsis 1 6 0.137 0.262 (0.951–1.714)
Multi organ dysfunction 4 7 0.837 0.898 (0.321–2.514)
Rash /splinter hemorrhage 0 4 0.091 –
•Previous history of infective endocarditis 1 0 0.204 –
•Murmur 2 8 0.149 0.393 (0.920–1.972)
•Raised infectious markers 1 2 0.837 0.786 (0.078–7.876)
Radiologic evidence on Echocardiography
•Vegetation 13 14 0.048 1.45 (1.03–2.066)
•Mitral valve prolapse 0 3 0.149 –
•Peri-annular abscess 2 3 0.956 1.048 (0.199–5.504)
•Valve perforation / dehiscence 1 1 0.740 1.571 (0.107–23.140)
•Portal hypertension 8 11 0.826 –
•Aortic regurgitation 6 10 0.878 0.943 (0.442–2.013)
•Mitral regurgitation 4 7 0.837 0.898 (0.321–2.514)
•Pulmonary regurgitation 2 0 0.068a –
HRG High risk group, NVG Native valve group, MoDC Modified Dukes Criteria
a= gangrene, unilateral weakness, slurring of speech, loss of consciousness
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markers, murmur, splenomegaly, rash, sepsis and splinter
hemorrhages and only two were treated surgically.
Amongst the 3 mortalities, 2 received medical treatment
only while one died at day 11 of hospital admission 24 h
post valvuloplasty. The patient presented with signs of
acute IE with MRSA (vancomycin MIC 1 μg/ml) and de-
veloped multiorgan dysfunction and pulmonary embolism.
This patient had multiple vegetations (11x11mm, 9x7mm)
on Tricuspid valve and underwent valve replacement due
to heart failure and sepsis. Infections with coagulase nega-
tive staphylococcal species was seen exclusively in the
HRG (n = 3), presenting with TE event, AKI, raised infec-
tious markers, splenomegaly and abscess on echocardio-
graph. Two of these patients were treated surgically and 1
medically, who later expired.
Discussion
In the 2-year study period, we enrolled 104 patients of
IE, of which 65.4% were definite cases based on MoDC.
Of enrolled cases 28.8% were culture negative as com-
pared with 50% previously reported in studies from
Pakistan [7, 8]. The most plausible explanation for this
difference is the sensitivity of blood and tissue culture
methods used in this study. Most etiological agents of IE
are fastidious and require highly nutrient culture
medium and controlled incubation conditions. BACTEC
9240 system of blood culture is known to have better
culture yield [12] as compared to conventional blood
culture method used in previous studies from Pakistan.
However when compared with data from western stud-
ies reporting blood culture yield of 90% [13] our culture
yield of 74.2% is much lower. The most compelling rea-
son for this low yield are the pre-analytical factors, such
as use of antibiotics prior to blood culture collection.
This was noticeable in 71% of all enrolled cases in
current study. Another important factor is the adequate
volume of blood cultured. Since density of microorgan-
isms in blood is often very low, adequate volume and
Table 3 Clinical outcome characteristics of IE patients admitted at AKUH 2015–2017 (n = 36)
CLINICAL OUTCOME HRG N = 14 NVG N = 22 p-value RISK
Disease severity 12 11 0.030 1.714 (1.072–2.741)
•Surgical management 7 15 0.275 1.571 (0.702–3516)
•Readmission 5 2 0.143 –
•Death 2 5 0.533 0.629 (.0141–2.808)
Presence of embolism / infarct 2 10 0.05 0.314 (0.080–1.227)
•Infarct 0 4 0.091 –
•Embolism 2 6 0.361 0.524 (0.122–2.240)
○Brain 0 6 0.032 –
○Lung 1 4 0.350 0.393 (0.049–3.165)
○limbs 1 0 0.204 –
Complication during hospital stay 5 6 0.592 1.310 (0.492–3.488)
Sepsis 1 1 0.740 1.571 (0.107–23.140)
•Coagulation / Hematological issue 2 2 0.629 1.571 (0.249–9.913)
•Multi-organ dysfunctiona 2 1 0.303 3.143 (0.314–31.506)
•Re- exploration 1 2 0.837 0.786 (0.078–7.876)
•Cardiac conduction defects 1 1 0.740 1.571 (0.107–23.140)
Indication for Surgical Intervention
•Sepsis 2 2 0.629 1.571 (0.249–9.913)
•Embolism 0 2 0.246 –
•Large vegetation 9 5 0.013 2.829 (1.192–6.710)
•Cardiac failure 0 4 0.091 –
Valve replacement 6 8 0.048
Cause of Death – – 0.852 –
•Cardiac arrest 1 2 0.852 –
•Cerebral bleed 0 1 0.143 –
•Sepsis 1 2 0.533 0.629 (.0141–2.808)
HRG High risk group, NVG Native valve group
a= acute renal injury (AKI), splenomegaly, hepatomegaly, lymphadenopathy, pulmonary symptoms
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multiple sampling is considered to be an important par-
ameter for improved blood culture yield. Guidelines
from most professional societies, such as American Soci-
ety for Microbiology (ASM) and Infectious Disease Soci-
ety of America (IDSA), recommend that adult patient
with suspected IE must be investigated by drawing at
least 3 blood culture sets with appropriate volume [1].
In our study population only 47.3% of total patients re-
cruited had 3 sets of blood culture. Inaccessibility to
health facilities, increasing diagnostic cost and lack of
awareness are factors that often contribute to poor com-
pliance to these essential pre-analytical components of
blood culture analysis in Pakistan.
Contrary to previous reports of predominantly younger
age group [3, 7] we found 15.4% of enrolled patients being
below age of 16 years. Tariq et al. in his study conducted in
2004 reported mean age of 24 years [3], same group in
2015 has reported a shift in mean age 42 years [4], close to
the mean age of patients in this study (34.5 years). This pro-
gressive increase perhaps reflects the shift in the underlying
risk factors. During the last two decades reports from
Pakistan are showing a gradual shift from communicable to
non-communicable diseases (NCDs) such as cardiovascular
diseases (including stroke and heart disease), diabetes, men-
tal health disorders, cancers, and chronic airway diseases
[14]. Management of most of these diseases often requires
advanced medical care such as use of cardiac implants, in-
vasive vascular interventions etc., predisposing patients to
risk factors of endocarditis similar to those of the modern
world –however more data is required to verify this change.
We found Streptococcus group of bacteria to be the
most frequently isolated organisms from blood and tis-
sue cultures in both groups. These findings are similar
to those published by other groups nationally and from
neighboring countries like China, India [3, 5, 7, 15–17]
as well as internationally [2, 18]. Although Streptococci
seem to predominate in developing regions, most west-
ern and developed parts of the world report S. aureus as
the predominant causative agent of IE [19, 20]. S. mitis
was the most common species isolated similar to a re-
cent survey involving 118 hospitals in Japan reporting
S.viridians as the predominant species in NVE [21].
Penicillin remains drug of choice against this group of
bacteria however we found 14.2% of our isolates to be
intermediately resistant with MIC as high as 1 μg/ml.
No particular species of S.viridans predominantly
showed higher MIC. The numbers of isolates in our
study were too few to establish such association. A study
in USA reported high-level penicillin resistance among
13.4% and intermediate resistance in 42.9% strains of S.
viridans [22].To the best of our knowledge no prospect-
ive study in Pakistan relates pathogens and their respect-
ive MICs with disease severity in IE, a finding unique to
our study.
Of the 18 S. aureus isolated, 77.7% were MRSA and
were more frequent in the NVG. MRSA infections
showed increase disease severity at time of presentation
such as TE events, AKI, raised infectious markers, mur-
mur splenomegaly, rash, sepsis and splinter hemor-
rhages. It was the commonest pathogen found amongst
Fig. 2 Kaplan Meier survival curves for high risk and native valve group. The Kaplan Meier curves show difference between the survival outcomes
of High risk group (HRG) and native valve group (NVG) which is statistically insignificant (p-value = 0.629)
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expired patients in both cohorts. A study in Turkey re-
ported 18% of IE deaths due to endocarditis, a number
higher than any other pathogen isolated [23]. This could
be due to the high prevalence of MRSA in the region.
Asia has higher prevalence of both healthcare-associated
methicillin-resistant Staphylococcus aureus (HA-MRSA)
and community-acquired methicillin-resistant S. aureus
(CA-MRSA) [24].
Human brucellosis is common in Pakistan in pa-
tients with risk factors such as animal exposure, use of
unpasteurized milk etc. Blood cultures positive for
patients suffering from Brucella infections are often
reported from this lab, however none of the cultures in
this study yielded Brucella sp., as a cause of endocardi-
tis. This could be because of selection bias of our
patients as most of the samples recruited in the study
were from patients under cardiac care. In addition, we
had limitation of non-availability of methods such as
PCR and serological analysis.
Embolism is not uncommon and risk is seen in 22–
57% cases of IE: the risk progressively increased with the
size of vegetation [25] . Amongst our patients 12 pre-
sented with evidence of embolism or infarct. Of these 6
were cerebral, 5 pulmonary and 1 with peripheral in-
volvement. A prospective multicenter European study
presented 34.1% cases with true embolic events [20].
Most were involving the CNS similar to our findings.
Statistically significant difference was seen between the 2
cohorts with more embolic events in the NVG. A retro-
spective study in France presented embolism in 62% of
PVE vs. 35% of NVE patients [25]. Although this contra-
dicts our findings, this could be due to delay in diagnosis
as patients with prior invasive intervention or cardiac
anomalies tend to access tertiary care earlier. Embolism
is directly related to the size of vegetations, therefore
late presentations are likely to have larger vegetations.
The mortality rate in our study was 19.4% and we saw
more deaths and more severe case presentations in
NVG as opposed to HRG (Table 3). This is most likely
due to inaccessibility to health facilities, increasing diag-
nostic cost leading to delay in diagnosis. HRG was asso-
ciated with severe disease outcomes, a statistically
significant finding despite a small sample size. These
were mainly due to higher rates of surgical intervention
and readmission due to complications. In a retrospective
review of surgical patients with NVE and PVE, Manne
et al. described a severe clinical course amongst those
with PVE, with 23% 1 year mortality rate, higher risk of
post-operative complication like cerebrovascular acci-
dent (3.3%), renal failure (11%), reoperation (9.4%) [9].
Our study had some limitations which included a small
sample size and convenient sampling. Ideally, an add-
itional control group comprising of uninfected surgical
cases should have been included to remove confounding
by surgical complications from those of complicated IE.
The sample size was small to establish statistically signifi-
cant findings. However, a larger sample size was not pos-
sible due to the low prevalence and short duration of this
prospective study.
Secondly, we could not ascertain culture negative
cases as we did not perform additional testing for organ-
isms like Bartonella spp., Coxiella burnetti and Tropher-
yma whipplei due to lack of technical facilities and
availability of reagents and positive control strains..
However for Mycobacterium tuberculosis culture was
performed in selected patients; cardiac tissue and pus as-
pirates when requested by the clinicians, and in this
study all MTb cultures remained negative. Being a single
center study, unrecognized confounding factors and se-
lection bias may have affected results. This study is
strengthened by its prospective nature as well as descrip-
tion of clinical details and disease outcomes relating to
pathogens in IE patients.
Conclusion
In conclusion our findings support the hypothesis that
HRG can encounter a more complicated clinical course
requiring further surgical interventions, readmissions or
death as opposed to native valve endocarditis patients
therefore we recommend close follow up of high risk
population.
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